Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks…

Akamai Technologies : FBN Securities maintains its outperform rating and reduces the target price from USD 120 to USD 110.
Arista Networks : Argus Research Company maintains its buy recommendation and raises the target price from USD 450 to USD 475.
Bristol-Myers Squibb Company : Deutsche Bank m…
© MarketScreener.com 2024